A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
Abner E, Stoszko M, Zeng L, Chen HC, Izquierdo-Bouldstridge A, Konuma T, Zorita E, Fanunza E, Zhang Q, Mahmoudi T, Zhou MM, Filion GJ, Jordan A.
Abner E, et al. Among authors: zhang q.
J Virol. 2018 Apr 27;92(10):e02056-17. doi: 10.1128/JVI.02056-17. Print 2018 May 15.
J Virol. 2018.
PMID: 29343578
Free PMC article.